50% off Premium Yearly

NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
MetLife Inc. (MET-N) has recently achieved a significant milestone by reaching a new 52-week high, signaling a strong performance in the market. Analysts characterize the company as solid, conservative, and defensive, suggesting that it has made prudent investments that align well with current market conditions. This reputation for stability is particularly appealing in times of market volatility, making MetLife an attractive option for risk-averse investors. With a focus on the right sectors, the company is positioned to endure economic fluctuations while potentially delivering steady returns to its shareholders. Overall, the positive sentiment surrounding MetLife reflects confidence in its strategic approach and long-term outlook.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Brian Acker, CA on 2019-06-14. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-16, Metlife (MET) stock closed at a price of $88.57.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.